The World Professional Association for Transgender Health (WPATH) is scheduled to convene its 2026 biennial conference in Mexico City from November 7 to 12, an event that arrives as the organization and its American affiliate, USPATH, face a mounting wave of legal challenges and federal oversight in the United States. While the conference is set to draw practitioners from across the globe, it is being led and organized largely by surgeons and medical professionals from prominent U.S. academic and healthcare institutions, many of whom are currently navigating a complex landscape of state-level bans and federal investigations.
The global summit is taking place under the shadow of an unprecedented lawsuit involving the Federal Trade Commission (FTC). Joined by four states, the litigation alleges that WPATH has made false and unsubstantiated claims regarding its self-generated “standards of care.” The lawsuit specifically targets the organization’s assertions that gender-transition drugs and surgical interventions for minors are consistently safe and effective. This legal pressure is compounded by ongoing federal investigations into potential billing fraud within the industry. These inquiries follow the release of a government report titled “Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of ‘Gender Medicine,’” which examines the financial motivations behind the expansion of pediatric gender services.
Despite the legal friction in the U.S., the WPATH 2026 committee is heavily populated by American medical figures. Among the lead organizers is Dr. Blair Peters, who manages the Transgender Health Program at Oregon Science and Health University (OSHU). Peters has previously drawn national attention in the U.S., notably during a 2023 House committee hearing where footage of his advocacy for experimental surgical techniques was used by Rep. Kat Cammack (R-Florida) to challenge the medical necessity of such procedures.
Joining Peters on the Surgeon’s Pre-Conference committee are other U.S.-based practitioners including Dr. Maurice Marcel Garcia, the Director of Trans Surgery at Cedars-Sinai in Los Angeles and an adjunct professor at the University of California, San Francisco (UCSF), and Dr. Nicolas Bene, who serves as the Director of Gender Affirming Surgery at Stanford University. The roster of involved U.S. surgeons also includes Marci Bowers and Johanna Olson Kennedy, widely considered pioneers in the field, as well as Dr. Thomas Satterwhite and Dr. John Pang of Align Surgical Associates in San Francisco. Other listed participants include Dr. Shane Morrison of the University of Washington and Seattle Children’s Hospital, and Dr. Jennifer Anger of the University of Arizona.
The conference program outlines a series of technical sessions and workshops focused on the mechanics of gender-affirming surgeries. Scheduled presentations include “Technique and Tissue Selection in Primary Vaginoplasty,” and discussions on “Phalloplasty Beyond the Radial Forearm Flap,” which explores alternative donor sites for surgical reconstruction. Other sessions, such as “How I Do It” workshops on clitoroplasty and vaginectomy, are designed to share specific surgical methodologies. One session, titled “Navigating the ‘Grey Zone’: Technique Selection in Gender-Affirming Top Surgery,” focuses on aesthetic and functional outcomes in chest reconstruction.
Ethical debates also follow some of the conference participants. Dr. Armand Antommaria, a pediatric ethicist from the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital, has previously faced scrutiny for his advocacy regarding a “ritual nick” for young girls to acknowledge cultural practices involving female genital procedures.
The conference is not merely a gathering of established surgeons but also serves as a training ground for the next generation of practitioners. It includes a Student Poster Competition and offers up to 44 credit hours of continuing medical education. These credits are sanctioned by major U.S. professional bodies, including the American Medical Association (AMA), the American Psychological Association (APA), the American Nurses Credentialing Center (ANCC), and the American Social Work Board (ASWB).
This push for international medical standardization occurs as the domestic policy environment in the U.S. continues to fragment. Currently, over half of U.S. states have enacted prohibitions or significant restrictions on gender-transition procedures for minors. Furthermore, the previous Trump administration moved to restrict these practices, reflecting a broader national debate over the long-term safety and psychological impact of medical transition.
As the WPATH 2026 conference approaches, the disconnect between the organization’s global expansion and its domestic legal hurdles remains a focal point for policymakers. Critics argue that the conference’s agenda ignores growing evidence of medical malpractice and harm, while the participating institutions continue to frame these procedures as essential healthcare. With federal investigations into hospital billing practices and the FTC’s focus on the validity of WPATH’s standards, the Mexico City summit may serve as a critical turning point for the trans-medical industry’s standing in American law and policy.
